Bioidentical Hormone Replacement Therapy (BHRT)

Bioidentical hormone replacement therapy (BHRT) programme including comprehensive hormonal blood panel evaluation, personalised therapy dosing, and ongoing monitoring. Available delivery methods include pellet therapy, topical creams and patches, and injections. May support energy, mood, metabolism, libido, and body composition. Indicated for perimenopause, menopause, andropause, and hormonally related fatigue or metabolic changes. 20% off first treatment.

Skinly Aesthetics' Bioidentical Hormone Replacement Therapy (BHRT) programme is a physician-supervised endocrine optimisation service led by Dr. Schwarzburg, encompassing initial hormonal evaluation, personalised therapy design, and ongoing laboratory monitoring. BHRT uses hormones that are molecularly identical to those produced endogenously by the human body — including estradiol, progesterone, testosterone, DHEA, and thyroid hormone — rather than the synthetic conjugated estrogens and progestins used in conventional HRT. The molecular identity to endogenous hormones is cited as a key distinction because bioidentical hormones bind to hormone receptors in the same way as the body's own hormones, whereas synthetic variants bind with different receptor specificity, which may contribute to the differing side effect and efficacy profiles observed in clinical practice. The programme begins with a comprehensive hormonal blood panel assessing sex hormones (estradiol, progesterone, total and free testosterone, DHEA-S, SHBG), metabolic markers (fasting insulin, cortisol, thyroid panel including TSH, fT3, fT4), and inflammatory markers — providing a detailed functional picture of the patient's endocrine status. Based on this evaluation and a symptom review consultation, Dr. Schwarzburg designs a personalised BHRT protocol selecting from three delivery methods: pellet therapy (small compressed hormone pellets inserted subcutaneously in the hip, releasing a steady dose over three to six months — often preferred for convenience and consistency of blood levels); topical creams and transdermal patches (applied daily for flexible dosing adjustment); or intramuscular or subcutaneous injections (typically weekly or bi-weekly). The programme includes follow-up laboratory testing to monitor hormone levels and titrate dosing. A 20% discount applies to the first treatment. Indications include perimenopause and menopause (women), andropause (men), adrenal fatigue, hormonally-related fatigue and low libido, and body composition challenges associated with age-related hormone decline.